
Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Join our newsletter and get the latest news